Cleared Traditional

DIAGNON FOLATE 125I RIA KIT (K841302) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K841302 · Diagnon Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1984
Decision
84d
Days
Class 2
Risk

K841302 is an FDA 510(k) clearance for the DIAGNON FOLATE 125I RIA KIT. Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Diagnon Corp. (Mchenry, US). The FDA issued a Cleared decision on June 22, 1984 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1295 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnon Corp. devices

Submission Details

510(k) Number K841302 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1984
Decision Date June 22, 1984
Days to Decision 84 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 88d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 63
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K841302.
Elecsys Folate III
K233060 · Roche Diagnostics · Jun 2024
Access Folate Assay
K223590 · Beckman Coulter, Inc. · Aug 2023
LIAISON® Folate
K192586 · DiaSorin, Inc. · May 2020
Atellica IM Folate Assay
K172201 · Siemens Healthcare Diagnostics, Inc. · Apr 2018
ELECSYS FOLATE III
K141426 · Roche Diagnostics · Oct 2014
ROCHE ELECSYS FOLATE RBC
K103716 · Roche Diagnostics · May 2011